Placenta Previa

1.  AUTHORVaitkuvene-A-P, Ventskauskas-A-V.
TITLE(Therapeutic tactics in placenta praevia). TT Taktika vracha pri predlezhanii platsenty.
SOURCEAkush-Ginekol (Mosk) 1989 Sep (9), P: 27-32, ISSN: 0300-9092.
ABSTRACTUltrasonic screening of pregnant females revealed 299 cases with placental presentation and the patterns of placenta migrations were established and studied. The area of placental presentation in various periods of pregnancy was estimated, anamnestic risk factors for abnormal progression of the pregnancy were identified, three patterns of placental migration were distinguished: rapid, moderate and slow. A model of placental migration was developed and the pregnancy management was pathogenetically substantiated and defined. Author.
2.  AUTHORFarine-D, Peisner-D-B, Timor-Tritsch-I-E.
INSTITUTIONDepartment of Obstetrics and Gynecology, Mt. Sinai Hospital, Toronto, Ontario, Canada.
TITLEPlacenta previa--is the traditional diagnostic approach satisfactory?
SOURCEJ-Clin-Ultrasound 1990 May, VOL: 18 (4), P: 328-30, ISSN: 0091-2751.
ABSTRACTThe accuracy of the diagnosis of placenta previa using transvaginal sonography (TVS) was compared to that of the traditional transabdominal sonography (TAS). Seventy seven women were scanned by both methods and each sonographic diagnosis was compared to the placental location at delivery. TVS was superior to TAS in diagnosing placenta previa and invariably correct in ruling it out. TVS (and TAS) failed to predict the placental location at delivery only in women diagnosed as having marginal placenta previa prior to 35 weeks gestation. The use of the vaginal probe significantly improved the accuracy of the diagnosis of placenta previa. Author.
3.  AUTHORTan-N-H, Abu-M, Woo-J-L, Tahir-H-M.
INSTITUTIONDepartment of Obstetrics and Gynaecology, Faculty of Medicine, National University of Malaysia, Kuala Lumpur.
TITLEThe role of transvaginal sonography in the diagnosis of placenta praevia.
SOURCEAust-N-Z-J-Obstet-Gynaecol 1995 Feb, VOL: 35 (1), P: 42-5, ISSN: 0004-8666.
ABSTRACTTransvaginal sonography was performed in 70 patients diagnosed to have placenta praevia by transabdominal sonography. The diagnosis was confirmed either by digital examination in theatre at term or operative finding at delivery. Forty-nine cases (70%) were correctly diagnosed to have placenta praevia by both modes of sonography. Transvaginal sonography ruled out placenta praevia in 12 cases (17%) thought to be placenta praevia by transabdominal ultrasound. Both transabdominal and transvaginal sonography demonstrated 'placental migration' in 4 cases (6%) which were no longer praevia at delivery. Five patients (7%) were erroneously believed to have placenta praevia by both sonographic techniques. Overall, the diagnostic accuracy of transvaginal sonography was 92.8% compared with 75.7% for transabdominal sonography. None of the subjects experienced any exacerbation of bleeding or other complications. The results suggest that transvaginal sonographic localization of the placenta is safe and superior to the transabdominal route. Author.
4.  AUTHORMabie-W-C.
INSTITUTIONDepartment of Obstetrics and Gynecology, University of Tennessee, Memphis.
TITLEPlacenta previa.
SOURCEClin-Perinatol 1992 Jun, VOL: 19 (2), P: 425-35, ISSN: 0095-5108 43 Refs.
ABSTRACTPlacenta previa occurs in approximately one in 200 pregnancies. The cause is unknown, but endometrial damage due to prior pregnancy, cesarean section, and other factors predispose to it. Diagnosis is usually made by transabdominal ultrasonography. False-positive diagnoses are common in the second trimester and the term "potential placenta previa" has been proposed to describe this situation. Bleeding with placenta previa is usually associated with uterine contractions, thus the introduction of tocolysis. Placenta accreta is common in the patient with one or more previous cesarean sections and placenta previa in the current pregnancy. Management of placenta previa is expectant and involves avoidance of digital vaginal examination, delay of delivery until 36 weeks' gestation and/or documented fetal lung maturity, transfusion support to maintain maternal hematocrit greater than or equal to 30%, serial ultrasonography, antepartum fetal heart rate monitoring, glucocorticoids, tocolytic therapy, and elective delivery by cesarean section. Maternal mortality is rare with placenta previa. Perinatal mortality is currently 4% to 8% primarily related to complications of prematurity. Author. Placenta previa occurs in approximately one in 200 pregnancies. The cause is unknown, but endometrial damage due to prior pregnancy, cesarean section, and other factors predispose to it. Diagnosis is usually made by transabdominal ultrasonography. False-positive diagnoses are common in the second trimester and the term "potential placenta previa" has been proposed to describe this situation. Bleeding with placenta previa is usually associated with uterine contractions, thus the introduction of tocolysis. Placenta accreta is common in the patient with one or more previous cesarean sections and placenta previa in the current pregnancy. Management of placenta previa is expectant and involves avoidance of digital vaginal examination, delay of delivery until 36 weeks' gestation and/or documented fetal lung maturity, transfusion support to maintain maternal hematocrit greater than or equal to 30%, serial ultrasonography, antepartum fetal heart rate monitoring, glucocorticoids, tocolytic therapy, and elective delivery by cesarean section. Maternal mortality is rare with placenta previa. Perinatal mortality is currently 4% to 8% primarily related to complications of prematurity. Author.
5.  AUTHORLove-C-D, Wallace-E-M.
INSTITUTIONSimpson Memorial Maternity Pavilion, Edinburgh.
TITLEPregnancies complicated by placenta praevia: what is appropriate management?
SOURCEBr-J-Obstet-Gynaecol 1996 Sep, VOL: 103 (9), P: 864-7, ISSN: 0306-5456.
ABSTRACT
   OBJECTIVE  To review the outcome of pregnancies complicated by placenta praevia over a three-year period (1991-1993) and to describe in detail the antenatal course and the events leading to delivery, assessing retrospectively whether there are clinical features predictive of outcome and whether outpatient management would be reasonable.
   DESIGN  A retrospective review of the case records of women with a pregnancy complicated by placenta praevia.
   SETTING  A tertiary referral teaching hospital in Edinburgh.
   RESULTS  There were 15,930 deliveries in the study period. Fifty-eight women (0.4%) had a placenta praevia in the third trimester, 42 of whom (72%) had at least one episode of bleeding. Overall, 62% of the women had a major praevia with no differences in the grade of praevia between those women who did or did not have bleeding. Both diagnosis and delivery occurred significantly earlier in women with antepartum bleeding than in those without (median gestation at diagnosis 28.6 weeks versus 33.3 weeks (P <0.01) and at delivery 36.0 weeks versus 37.1 weeks (P="0.04)," respectively). Delivery by emergency caesarean section was more common in women with bleeding (62% versus 38%). An increasing number of bleeding episodes experienced by individuals was not associated with significant differences in outcomes. Rapid emergency delivery for bleeding was necessary for three women, in none of whom could the bleeding have been predicted.
   CONCLUSION  The clinical outcomes of placenta praevia are highly variable and cannot be predicted confidently from antenatal events. Nonetheless, in the majority of cases with or without bleeding and irrespective of the degree of praevia, outpatient management would appear safe and appropriate. Author.
6.  AUTHORWing-D-A, Paul-R-H, Millar-L-K.
INSTITUTIONDepartment of Obstetrics-Gynecology, University of Southern California School of Medicine, Los Angeles 90033, USA.
TITLEManagement of the symptomatic placenta previa: a randomized, controlled trial of inpatient versus outpatient expectant management.
SOURCEAm-J-Obstet-Gynecol 1996 Oct, VOL: 175 (4 Pt 1), P: 806-11, ISSN: 0002-9378.
ABSTRACT
   OBJECTIVE  Our purpose was to determine the safety, efficacy, and costs of inpatient and outpatient management of symptomatic placenta previa.
   STUDY   DESIGN  Fifty-three women with the initial diagnosis of placenta previa at 24 to 36 weeks' gestation who required hospitalization for vaginal bleeding were stabilized and then randomized to receive either inpatient or outpatient expectant management. Twenty-seven inpatients were placed at bed rest with minimal ambulation, received weekly corticosteroids until 32 weeks of gestation, and underwent ultrasonographic examination at 2-week intervals to assess fetal growth and placental location. Twenty-six outpatients were discharged home after > or = 72 hours of hospitalization. Each week they also received corticosteroids, until 32 weeks' gestation, and ultrasonographic evaluations. Outpatients with recurrent bleeding were readmitted for evaluation. All subjects who reached 36 weeks' gestation with persistent placenta previa underwent amniocentesis. When fetal lung maturity was present, cesarean delivery was electively performed.
   RESULTS  There were insignificant differences between inpatients and outpatients for mean age, parity, race, type of previa (complete or partial), number of prior vaginal bleeding episodes, and initial hemoglobin value. The mean estimated gestational age at enrollment was 29.1 +/- 3.1 (SD) weeks for inpatients and 29.9 +/- 3.1 weeks for outpatients. In eight patients the placenta was found to no longer cover the internal os by 36 weeks' gestation. There were seven patients in each group who did not complete the protocol for initial treatment assignment. The average estimated gestational age at delivery for the inpatients was 34.5 +/- 2.4 weeks and 34.6 +/- 2.3 weeks for the outpatients (p = 0.90), whereas the mean birth weights were 2413.7 +/- 642.7 gm and 2607.8 +/- 587.1 gm, respectively (p = 0.28). Thirty-three patients (62.3%) had recurrent episodes of bleeding, with 26 requiring expeditious cesarean delivery. Four (14.8%) inpatients and one (3.7%) outpatient required blood transfusion (p = 0.67). There was no difference in neonatal morbidity (defined as the presence of respiratory distress syndrome, intracranial hemorrhage, or culture- proved sepsis) between the two groups (relative risk 1.16, 95% confidence interval 0.66 to 2.02). There were no neonatal deaths. The mean number of maternal hospital days differed significantly between the two groups: inpatients required an average of 28.6 +/- 20.3 days and outpatients remained hospitalized for an average of 10.1 +/- 8.5 days (p <0.0001). Cost analysis based on maternal hospital days reveals a net savings of +15,080 per patient if women with symptomatic placenta previa initially diagnosed before 37 weeks' gestation are treated as outpatients.
   CONCLUSION  For selected patients, outpatient management of symptomatic placenta previa appears to be an acceptable alternative to traditional conservative expectant inpatient management. Author.
7.  AUTHORDroste-S, Keil-K.
INSTITUTIONDepartment of Obstetrics and Gynecology, University of Wisconsin-Madison.
TITLEExpectant management of placenta previa: cost-benefit analysis of outpatient treatment.
SOURCEAm-J-Obstet-Gynecol 1994 May, VOL: 170 (5 Pt 1), P: 1254-7, ISSN: 0002-9378.
ABSTRACT
   OBJECTIVE  In this study outpatient and inpatient expectant management for complete placenta previa were compared in terms of maternal and neonatal outcome and overall cost.
   STUDY   DESIGN  We reviewed the outcomes and hospital costs of 72 mother-infant pairs where the pregnancy was complicated by second- or third-trimester placenta previa and was managed expectantly either with hospitalization or outpatient bed rest. The data were analyzed with the two-sided unpaired t test, chi 2, and simple correlation analysis.
   RESULTS  There were no differences in maternal morbidity as measured by estimated total blood loss, number of blood transfusions, nadir hematocrit, or need for emergency delivery. Fetal mortality was comparable in both groups, and there were no significant differences in neonatal morbidity as measured by gestational age, birth weight, 5-minute Apgar score, or occurrence of fetal distress. Among outpatients the number of maternal hospital days was reduced by 50% (p <0.01). Outpatient management achieved a hospital cost reduction of 48.5% for mothers (p < 0.001) and 39.4% for mother-infant pairs (p < 0.05).
   CONCLUSION  In selected patients outpatient management of complete placenta previa can be cost-effective and safe. Author.
8.  AUTHORSilver-R, Depp-R, Sabbagha-R-E, Dooley-S-L, Socol-M-L, Tamura-R-K.
INSTITUTIONDepartment of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, Illinois.
TITLEPlacenta previa: aggressive expectant management.
SOURCEAm-J-Obstet-Gynecol 1984 Sep 1, VOL: 150 (1), P: 15-22, ISSN: 0002-9378.
ABSTRACTWe report the outcomes of 95 expectantly managed cases of placenta previa; all were diagnosed after 21 weeks' gestation. Patients at risk for preterm delivery because of hemorrhage or preterm labor received aggressive care, including multiple transfusions, volume expansion and tocolytic therapy, and amniotic fluid surfactant determinations, to achieve the goal of delivery at 37 weeks' gestation with mature fetal lung function. We present guidelines for outpatient management and double setup examination prior to delivery. The role of ultrasound in diagnosis (three asymptomatic cases; 13 cases with preterm labor) and serial placental localization to determine the timing, route, and place of delivery is presented. Eighty-six percent of 19 infants born weighing less than 2500 gm were managed expectantly. Hemorrhage was the determinant in delivery timing in 50 cases. All four deaths were neonatal with birth weights less than 2200 gm. This is the lowest perinatal mortality rate (4.2%) published to date. Use of this aggressive approach is particularly suitable for patients cared for in a teritary center. Author.

[Return to article]

Copyright © 2009 Electronic Handbook of Legal Medicine